18.
The blood cancer that shows China is winning drug discovery (t.co)
Multiple myeloma has become a concrete case study in China’s accelerating ability to turn biotech research into clinically important therapies
@RuxandraTeslo on Backlist
2 appearances on the backlist front page in the last 30 days.
25.
Biotech policy debates should account for patients seeking Phase I access
For some patients, access to an early clinical trial abroad can be a life-changing medical option rather than an abstract geopolitics issue